Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$197.11 - $250.07 $394 - $500
-2 Reduced 22.22%
7 $1,000
Q2 2022

Aug 10, 2022

BUY
$204.13 - $302.4 $1,837 - $2,721
9 New
9 $2,000
Q1 2022

May 11, 2022

SELL
$255.51 - $362.11 $2,299 - $3,258
-9 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$351.38 - $448.68 $3,162 - $4,038
9 New
9 $3,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Lee Financial CO Portfolio

Follow Lee Financial CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

News

Stay updated on Lee Financial CO with notifications on news.